Bsenexus Terminal Open in Bsenexus App →
OTHER BSE: 539523

Alkem Laboratories Ltd

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Alkem Laboratories Limited launches NeuCeno (cenobamate) for the treatment of partial - onset seizures in adult patients.